 Glenmark PharmaceuticalsPharmaceuticals | Glenmark's US arm launches Calcium Gluconate Injection in US market21 Aug 2026Regulatory Product Approval×6 | pending | ₹2,318 | 65,411 Cr | 46.4vs 28.5 | 14.7% | -37.6% |
 Anant RajResidential Commercial Projects | Anant Raj gets RERA registration for Gurugram luxury housing project20 Aug 2026Regulatory Product Approval | pending | ₹624 | 22,451 Cr | 37.5vs 22.3 | 10.2% | +2.5% |
 Colgate PalmolivePersonal Care | Colgate PerioGard earns ISP Seal of Acceptance — first in India18 Aug 2026Regulatory Product Approval | +0.4% — — | ₹1,889 | 51,381 Cr | 37.9vs 37.9 | 107.1% | +5.0% |
 Acutaas ChemicalsPharmaceuticals | Acutaas gets govt ECMS incentive approval for Electrolyte Additives unit18 Aug 2026Regulatory Product Approval | +1.0% — — | ₹3,170 | 25,953 Cr | 61.8vs 28.5 | 27.5% | +41.3% |
 Biocon Limited.Pharmaceuticals | Biocon gets U.S. FDA nod for Yesintek autoinjector format18 Aug 2026Regulatory Product Approval×4 | +0.2% — — | ₹416 | 67,361 Cr | 111.1vs 28.5 | 0.9% | +5.2% |
 LupinPharmaceuticals | Lupin gets US FDA approval for Pitolisant Tablets generic17 Aug 2026Regulatory Product Approval×12 | -0.1% — — | ₹2,202 | 1.01 L Cr | 19.1vs 28.5 | 26.7% | +6.1% |
 Zydus LifesciencesPharmaceuticals | Zydus launches REVAHALE, India's first once-daily nebulised LAMA for COPD10 Aug 2026Regulatory Product Approval×6 | +7.2% -1.0% — | ₹1,120 | 1.13 L Cr | 24.3vs 28.5 | 18.0% | +23.9% |
 DelhiveryLogistics Solution Provider | RBI grants NBFC registration to Delhivery Financial Services subsidiary4 Aug 2026Regulatory Product Approval×2 | -0.9% -1.4% — | ₹451 | 33,740 Cr | 333.9vs 16.2 | 1.2% | +11.4% |
 Sun Pharmaceutical Ind LPharmaceuticals | Sun Pharma gets Brazil approval to market semaglutide for diabetes29 Jul 2026Regulatory Product Approval×4 | -0.3% -2.4% — | ₹1,902 | 4.56 L Cr | 37.6vs 28.5 | 17.5% | +0.9% |
 Gland PharmaPharmaceuticals | Gland Pharma gets USFDA approval for Sugammadex Injection, Day 1 launch29 Jul 2026Regulatory Product Approval | +3.6% +6.1% — | ₹2,812 | 46,331 Cr | 36.9vs 28.5 | 13.4% | +17.2% |
 DR. Reddy S LaboratoriesPharmaceuticals | Dr Reddy's confirms Thailand approval for gonorrhoea drug NUZOLVENCE29 Jul 2026Regulatory Product Approval | +0.9% +3.0% — | ₹1,175 | 98,087 Cr | 34.2vs 28.5 | 13.0% | -14.5% |
 CiplaPharmaceuticals | Cipla gets US FDA approval for Generic Advair Diskus27 Jul 2026Regulatory Product Approval | +4.2% +4.4% — | ₹1,432 | 1.16 L Cr | 47.0vs 28.5 | 14.7% | -13.8% |
 Aurobindo PharmaPharmaceuticals | ANVISA approval for CuraTeQ Biologics biosimilars facility in Hyderabad21 Jul 2026Regulatory Product Approval×2 | -3.7% -0.2% — | ₹1,621 | 94,165 Cr | 25.7vs 28.5 | 12.6% | +6.8% |
 GMR AirportsAirport & Airport services | GMR Airports June 2026 traffic update: DEL grows, HYD and Goa decline15 Jul 2026Regulatory Product Approval×2 | -1.4% -3.6% -9.6% | ₹99.63 | 1.05 L Cr | 203.3 | 0.8% | +7.3% |
 Timken IndiaAbrasives & Bearings | Please find attached press release regarding BIS Licenses obtained by Timken India Limited.
This is for your information and record.13 Jul 2026Regulatory Product Approval×2 | +0.5% -2.2% +3.7% | ₹3,159 | 23,759 Cr | 88.8vs 95.2 | 18.4% | — |
 Granules IndiaPharmaceuticals | Granules gets Sole First-to-File status for Sodium Oxybate generic ANDA in US6 Jul 2026Regulatory Product Approval | +3.7% +8.1% +0.9% | ₹860 | 21,311 Cr | 29.8vs 28.5 | 13.9% | +13.4% |
 One 97 CommunicationsFinancial Technology (Fintech) | Paytm's Luxembourg unit gets payment institution license from CSSF3 Jul 2026Regulatory Product Approval×2 | +0.5% +14.3% +16.4% | ₹1,632 | 1.04 L Cr | 127.7vs 90.9 | 3.6% | +9.8% |
 Bharti AirtelTelecom - Cellular & Fixed line services | Bharti Airtel subsidiary Airtel Money starts NBFC operations1 Jul 2026Regulatory Product Approval | +2.1% +1.8% +5.4% | ₹1,946 | 11.86 L Cr | 40.6vs 23.1 | 11.9% | +6.2% |
 Oberoi RealtyResidential Commercial Projects | Oberoi Realty clarifies on RERA registration for Gurugram project24 Jun 2026Regulatory Product Approval | +0.5% +8.7% +4.3% | ₹1,886 | 68,575 Cr | 25.9vs 22.3 | 15.5% | -36.8% |
 Affle 3IIT Enabled Services | Affle 3i gets Indian patent for click-to-install fraud detection24 Jun 2026Regulatory Product Approval | -1.4% -0.9% -0.2% | ₹1,720 | 24,180 Cr | 50.5vs 19.6 | 15.2% | +12.0% |
 Hindustan CopperCopper | Forest Clearance granted for Chandmari copper mine in Rajasthan24 Jun 2026Regulatory Product Approval | -1.9% -0.8% -3.2% | ₹573 | 55,420 Cr | 46.1 | 34.5% | +61.0% |
 WockhardtPharmaceuticals | Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release - "Wockhardt Receives U.S. FDA Approval for ZAYNICH (cefepime and zidebactam), a Novel Intravenous Antibiotic ....30 May 2026Regulatory Product Approval×4 | -2.6% -9.0% -2.8% | ₹1,888 | 30,586 Cr | 68.2vs 28.5 | 3.4% | +23.4% |
